A researcher from Stephenson Cancer Center at Oklahoma University (OU) Medicine received a grant from the U.S. Department of Defense to explore a means by which tumor cells may be avoiding detection in lung cancer. A unique study, the patients will be studied in real-time as they participate in clinical trial involving immunotherapy medication.
Cancerous tumor cells are intelligent—they disguise themselves, hide and find ways to evade the immune cells out to kill them. Beating cancer means figuring out ways to take those evasive powers away. Hence, OU’s Rajagopal Ramesh, PhD, recently received the Department of Defense (DOD) grant to examine, during an immunotherapy trial, in collaboration with MRI and CT imaging, how and why cancer cells can resist immunotherapy. It is the first such study in Oklahoma.